Beresford SA - Search Results

1

Pregnancy history and risk of endometrial cancer.

Pocobelli G, Doherty JA, Voigt LF, Beresford SA, Hill DA, Chen C, Rossing MA, Holmes RS, Noor ZS, Weiss NS. Pocobelli G, et al. Among authors: beresford sa. Epidemiology. 2011 Sep;22(5):638-45. doi: 10.1097/EDE.0b013e3182263018. Epidemiology. 2011. PMID: 21691206 Free PMC article.

2

Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer.

Doherty JA, Cushing-Haugen KL, Saltzman BS, Voigt LF, Hill DA, Beresford SA, Chen C, Weiss NS. Doherty JA, et al. Among authors: beresford sa. Am J Obstet Gynecol. 2007 Aug;197(2):139.e1-7. doi: 10.1016/j.ajog.2007.01.019. Am J Obstet Gynecol. 2007. PMID: 17689625

3

Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.

Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, Weiss NS. Saltzman BS, et al. Among authors: beresford sa. Am J Epidemiol. 2008 Mar 1;167(5):607-14. doi: 10.1093/aje/kwm333. Epub 2007 Dec 10. Am J Epidemiol. 2008. PMID: 18071194

4

Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States).

Green PK, Weiss NS, McKnight B, Voigt LF, Beresford SA. Green PK, et al. Among authors: beresford sa. Cancer Causes Control. 1996 Nov;7(6):575-80. doi: 10.1007/BF00051699. Cancer Causes Control. 1996. PMID: 8932917

5

Endometrial cancer in relation to intra-uterine device use.

Hill DA, Weiss NS, Voigt LF, Beresford SA. Hill DA, et al. Among authors: beresford sa. Int J Cancer. 1997 Jan 27;70(3):278-81. doi: 10.1002/(sici)1097-0215(19970127)70:3<278::aid-ijc5>3.0.co;2-u. Int J Cancer. 1997. PMID: 9033627

6

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.

Beresford SA, Weiss NS, Voigt LF, McKnight B. Beresford SA, et al. Lancet. 1997 Feb 15;349(9050):458-61. doi: 10.1016/S0140-6736(96)07365-5. Lancet. 1997. PMID: 9040575

7

Menopausal hormone use and endometrial cancer, by tumor grade and invasion.

Shapiro JA, Weiss NS, Beresford SA, Voigt LF. Shapiro JA, et al. Among authors: beresford sa. Epidemiology. 1998 Jan;9(1):99-101. Epidemiology. 1998. PMID: 9430277

8

Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens.

Cushing KL, Weiss NS, Voigt LF, McKnight B, Beresford SA. Cushing KL, et al. Among authors: beresford sa. Obstet Gynecol. 1998 Jan;91(1):35-9. doi: 10.1016/s0029-7844(97)00577-2. Obstet Gynecol. 1998. PMID: 9464717

9

The additional risk of endometrial cancer associated with unopposed estrogen use in women with other risk factors.

Shields TS, Weiss NS, Voigt LF, Beresford SA. Shields TS, et al. Among authors: beresford sa. Epidemiology. 1999 Nov;10(6):733-8. Epidemiology. 1999. PMID: 10535788

10

Continuous combined hormone replacement therapy and risk of endometrial cancer.

Hill DA, Weiss NS, Beresford SA, Voigt LF, Daling JR, Stanford JL, Self S. Hill DA, et al. Among authors: beresford sa. Am J Obstet Gynecol. 2000 Dec;183(6):1456-61. doi: 10.1067/mob.2000.108081. Am J Obstet Gynecol. 2000. PMID: 11120510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters